Articles Tagged With:
-
Comments to OSHA on ETS: ‘Too Much, Too Late’
Some of the comments received by the Occupational Safety and Health Administration on its Emergency Temporary Standard on COVID-19 in healthcare show frustration and disappointment.
-
OSHA Emergency COVID-19 Reg May Drive More Vaccine Mandates
Federal occupational health officials are being blasted for an Emergency Temporary Standard requiring potentially labor-intensive changes to address a pandemic threat that is diminishing as vaccinations increase.
-
Clinical Research as an Equalizer
Differences in outcomes and responses to treatment in diverse populations often have been attributed to biological factors. However, standardized treatment can tell a divergent story, one in which parameters, such as geographic location and financial status, play a significant role in how a person responds. This underscores the importance of a diverse study population in clinical trials, researchers say. -
Prepare for an Unexpected PI Transition
Contemplating death can be uncomfortable, but by planning ahead, researchers can find peace in knowing their life’s work continues beyond their physical presence. -
Ethics of Fertility Preservation for Transgender and Nonbinary Youth
In an updated policy statement, the American Society for Reproductive Medicine says transgender status should not prevent a patient from accessing fertility preservation. Further, reproductive services should be offered to all interested transgender or nonbinary individuals, barring other disqualifying factors (based on empirical evidence as opposed to bias or stereotypes). -
Dexmedetomidine Compared to Propofol for Sedation in Mechanically Ventilated Patients with Sepsis
The MENDS2 trial found that dexmedetomidine, when used for light sedation, had outcomes similar to those for propofol. -
Day-Long Ethics Training for Graduate Students Is Effective
A shorter program could be more useful for smaller universities that may not have the resources available to implement a longer program. -
Interleukin-6 Antagonists in the Treatment of Severe COVID-19 Pneumonia
These two trials had disparate findings with respect to interleukin-6 inhibition, with REMAP-CAP showing a benefit and COVACTA showing none. -
Is There a Role for Immunomodulatory Therapy in COVID-19 Cytokine Storm?
In this retrospective analysis of COVID-19 patients hospitalized with cytokine storm, the use of corticosteroids combined with tocilizumab was associated with superior survival when compared to no immunomodulatory treatment; a combination of corticosteroids and anakinra; or corticosteroids, tocilizumab, or anakinra alone. Patients who received corticosteroids, either alone or in combination with anakinra, also experienced lower hospital mortality compared to no treatment. -
Community Input Ensures Ethical Informed Consent
By including ordinary people, researchers could create consent forms, and a consenting process, that is primarily suited to meeting the needs of potential participants.